Zenas BioPharma, Inc. share price logo

Zenas BioPharma, Inc.

NASDAQ: ZBIO

Small Cap

$28.73

+1.11

(+4.04%)

Live

as on

Zenas BioPharma, Inc. Stock Performance

as on November 4, 2026 at 4:58 am IST

  • Day's Low

    Day's High

    $28.19
    $29.05
    downward going graph

    1.88%

    Downside

    1.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.50
    $44.60
    downward going graph

    53.01%

    Downside

    55.24%

    Upside

    downward going graph

Zenas BioPharma, Inc. share price movements today

Previous Close
$27.62
Open
$28.19
Volume
195.5K
Market Cap
$1.9B
Day's Low - High
$28.19 - $29.05
52 Week Low - High
$13.50 - $44.60

Zenas BioPharma, Inc. Historical Returns

1 Month Return
-2.39 %
3 Month Return
-11.28 %
1 Year Return
-11.84 %
3 Year Return
0 %
5 Year Return
0 %

Zenas BioPharma, Inc. Stock Fundamentals & Key Indicators

Check Zenas BioPharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-9.62

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.95

Industry PE ratio

-9.79

PEG Ratio

0.03

EBITDA

-457.3M

Revenue (TTM)

1.0M

Profit Margin

-5972.60%

Return On Equity TTM

-189.68%

Zenas BioPharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zenas BioPharma, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Zenas BioPharma, Inc. image
Zenas BioPharma, Inc.
Buy$1.9BNA-2.95-5972.60%0.00%
Moderna image
Moderna
Neutral$88.5B-36.16%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Zenas BioPharma, Inc. Stock including INR - Dollar returns

The Zenas BioPharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 7Y

  • 10Y

Zenas BioPharma, Inc. investment value today

Current value as on today

₹97,920

Returns

-₹2,080

(-2.08%)

Returns from Zenas BioPharma, Inc. Stock

-₹8,299 (-8.3%)

Dollar Impact

₹6,218 (+6.22%)

Analyst Recommendation on Zenas BioPharma, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Zenas BioPharma, Inc.. Average target price of $46

Zenas BioPharma, Inc. Share Price Target

Get share price movements and forecasts by analysts on Zenas BioPharma, Inc..

Current Price

$28.73

Analyzed by

2 Analysts

High

$48

0

Low

$44

Zenas BioPharma, Inc. target price $0, a slight upside of 0% compared to current price of $28.73. According to 2 analysts rating.

Indian Investors' Interest in Zenas BioPharma, Inc. Stock

Search interest for Zenas BioPharma, Inc. Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Zenas BioPharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
5
10
-
-
-
-
1
Gross Profit
-22
-33
-33
5
10
-43
-5
-55
0
1
Operating Income
-27
-39
-40
-55
-37
-55
-52
-237
-77
-107
EBITDA
-27
-37
-38
-52
-33
-52
-51
-230
-74
-101
Interest Expense
-
-
-
-
-
-
-
-
6
10
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Income Tax Expense
-
-
-
0
0
0
-
0
-
0
Net Income
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
100.00%

Zenas BioPharma, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
50
5
10
Gross Profit
-61
50
-134
10
Operating Income
-76
-37
-163
-211
EBITDA
-75
-27
-156
-370
Interest Expense
-
-
-
7
Depreciation
0
0
0
0
Income Before Tax
-119
-36
-156
-377
Income Tax Expense
-
0
0
0
Net Income
-119
-37
-156
-377
Net Profit Margin
0.00%
100.00%
-2682.78%
100.00%

Zenas BioPharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Operating Cash Flow
-19
-30
-31
-38
-37
-41
-41
-52
-75
-57
Investing Cash Flow
0
0
-26
-3
-86
-112
40
-93
31
-287
Financing Cash Flow
0
177
233
1
0
1
72
140
433
42
Change in Cash
-19
146
176
-40
-123
-152
71
-4
389
-303

Zenas BioPharma, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-119
-37
-156
-377
Operating Cash Flow
-65
-30
-119
-172
Investing Cash Flow
-2
0
-30
-251
Financing Cash Flow
59
20
412
215
Change in Cash
-8
-10
262
-209

Global Institutional Holdings in Zenas BioPharma, Inc.

Check out the Institutions with significant holdings in Zenas BioPharma, Inc..

Funds
Holdings
Jason Raleigh Nunn
4.79%
VANGUARD SPECIALIZED FUNDS
4.51%
BlackRock, Inc.
4.12%
Patrick Enright
4.02%
SMALLCAP World Fund Inc
3.73%
See all

Insights on Zenas BioPharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, ZBIO stock has moved up by 42.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 798.3%

About Zenas BioPharma, Inc.

Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
OrganisationZenas BioPharma, Inc.
Headquarters852 Winter Street, Waltham, MA, 02451, US
IndustryBiotechnology
CEOLeon Oliver Moulder Jr.

Key Management of Zenas BioPharma, Inc.

Name

Title

Mr. Leon Oliver Moulder Jr., M.B.A.

Founder, CEO & Chairman

Mr. Joseph L. Farmer

COO, President, Principal Financial Officer & Principal Accounting Officer

Dr. Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Dr. Heinrich Schlieker Ph.D.

Chief Technical Officer

Dr. Haley Laken Ph.D.

Chief Scientific Officer

Ms. Caroline Chevalier

Chief Administrative Officer

FAQs

What is Zenas BioPharma, Inc. share price today?

Zenas BioPharma, Inc. share price today is $28.73 as on . Zenas BioPharma, Inc. share today touched a day high of $29.05 and a low of $28.19.

What is the 52 week high and 52 week low for Zenas BioPharma, Inc. share?

Zenas BioPharma, Inc. share touched a 52 week high of $44.60 on and a 52 week low of $13.50 on . Zenas BioPharma, Inc. stock price today i.e. is trending at $28.73,which is 35.58% down from its 52 week high and 112.81% up from its 52 week low.

What is Zenas BioPharma, Inc.'s market capitalisation today?

Zenas BioPharma, Inc. market capitalisation is $0.00T as on .

How to invest in Zenas BioPharma, Inc. Stock (ZBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zenas BioPharma, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Zenas BioPharma, Inc. Stock (ZBIO) from India?

Indian investors can start investing in Zenas BioPharma, Inc. (ZBIO) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Zenas BioPharma, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Zenas BioPharma, Inc. share’s latest price of $28.73 as on November 3, 2026 at 11:28 pm IST, you will get 0.3481 shares of Zenas BioPharma, Inc.. Learn more about fractional shares .